Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menglytate, also known as menthyl ethoxyacetate, is an investigational small molecule compound characterized by its antitussive and local anesthetic properties. Chemically, it is an ester formed from menthol and ethoxyacetic acid, specifically the 2-ethoxyacetic acid ester of (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl. The compound is primarily utilized as an active ingredient in medicinal products designed to alleviate cough and throat irritation. It has historically appeared in combination formulations such as Coryfin C, where it is paired with vitamin C. While it has a history of use in over-the-counter throat lozenges, it remains classified as an investigational drug in modern pharmacological databases such as NCATS.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menglytate.